Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure

• Author(s): Nicolau, José Carlos
• Date: 2019
• Origin: Oasisbr
• Subject(s): RESULTADO DE TRATAMENTO
• Document Type: Journal article
• Language: English